Your browser doesn't support javascript.
loading
Overexpression of Desmoglein 2 in a Mouse Model of Gorlin Syndrome Enhances Spontaneous Basal Cell Carcinoma Formation through STAT3-Mediated Gli1 Expression.
Brennan-Crispi, Donna M; Overmiller, Andrew M; Tamayo-Orrego, Lukas; Marous, Molly R; Sahu, Joya; McGuinn, Kathleen P; Cooper, Felicia; Georgiou, Ioanna Ch; Frankfurter, Maxwell; Salas-Alanis, Julio C; Charron, Frédéric; Millar, Sarah E; Mahoney, My G; Riobo-Del Galdo, Natalia A.
Afiliação
  • Brennan-Crispi DM; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Penns
  • Overmiller AM; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Biochemistry and Pharmacology Graduate Program, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Tamayo-Orrego L; Molecular Biology of Neural Development, Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada; Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada.
  • Marous MR; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Sahu J; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • McGuinn KP; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Cooper F; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Georgiou IC; Leeds Institute of Cancer and Pathology, University of Leeds, UK; School of Molecular and Cellular Biology, University of Leeds, United Kingdom.
  • Frankfurter M; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Salas-Alanis JC; Center for Molecular Diagnostics and Personalized Medicine, University of Monterrey, Mexico.
  • Charron F; Molecular Biology of Neural Development, Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada; Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada; Department of Biology, Department of Anatomy and Cell Biology, and Department of Medicine, McGill Un
  • Millar SE; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Mahoney MG; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: My.Mahoney@jefferson.edu.
  • Riobo-Del Galdo NA; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Leeds Institute of Cancer and Pathology, University of Leeds, UK; School of Molecular and Cellula
J Invest Dermatol ; 139(2): 300-307, 2019 02.
Article em En | MEDLINE | ID: mdl-30291846
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Síndrome do Nevo Basocelular / Fator de Transcrição STAT3 / Desmogleína 2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Síndrome do Nevo Basocelular / Fator de Transcrição STAT3 / Desmogleína 2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article